Cargando…

Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation

SARS-CoV-2 has spread rapidly worldwide, but the full impact of the COVID-19 pandemic on the field of hematopoietic cell transplantation (HCT) remains unknown. To understand this better, an 18-item online survey was disseminated by the Worldwide Network for Blood & Marrow Transplantation with qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Worel, Nina, Shaw, Bronwen E., Aljurf, Mahmoud, Koh, Mickey, Seber, Adriana, Weisdorf, Daniel, Schwartz, Joseph, Galeano, Sebastian, Kodera, Yoshihisa, Eldridge, Paul W., Hashmi, Shahrukh, Atsuta, Yoshiko, Szer, Jeff, Saber, Wael, Niederwieser, Dietger, Greinix, Hildegard T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Transplantation and Cellular Therapy. 2021
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834678/ https://www.ncbi.nlm.nih.gov/pubmed/33781537 http://dx.doi.org/10.1016/j.jtct.2020.11.019

Ejemplares similares

“Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries”
por: Aljurf, Mahmoud, et al.
Publicado: (2019)

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
por: Niederwieser, Dietger, et al.
Publicado: (2021)

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
por: Algwaiz, Ghada, et al.
Publicado: (2020)

The Chinese HCT survey: a non-manipulated haploidentical transplantation procedure makes a novel contribution to data sharing within the regional and global transplant registries and to worldwide knowledge
por: Niederwieser, Dietger
Publicado: (2021)

Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
por: Gratwohl, Alois, et al.
Publicado: (2019)

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
por: Majhail, Navneet Singh, et al.
Publicado: (2012)

Lower Genital Tract Precancer and Cancer in Hematopoietic Cell Transplant Survivors and the Role of HPV: A Systematic Review and Future Perspectives
por: Tanweer, Mohammad Shahrukh, et al.
Publicado: (2019)

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
por: Szer, Jeff, et al.
Publicado: (2020)

The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the world
por: Okamoto, Shinichiro, et al.
Publicado: (2022)

Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature
por: Brockmann, Jens G., et al.
Publicado: (2018)

Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
por: El Fakih, Riad, et al.
Publicado: (2017)

Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation
por: Brauer, Dominic, et al.
Publicado: (2021)

EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression - a case report
por: Krenauer, Alexander, et al.
Publicado: (2010)

Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT
por: Frankiewicz, Andrzej, et al.
Publicado: (2020)

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
por: Hamadani, Mehdi, et al.
Publicado: (2020)

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)

Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

Artificial Intelligence Approaches in Hematopoietic Cell Transplantation: A Review of the Current Status and Future Directions
por: Muhsen, Ibrahim N., et al.
Publicado: (2018)

Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
por: Robak, Oliver, et al.
Publicado: (2016)

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older
por: Backhaus, Donata, et al.
Publicado: (2022)

Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
por: Socié, Gerard, et al.
Publicado: (2023)

Biosimilar agents in oncology/haematology: from approval to practice
por: Niederwieser, Dietger, et al.
Publicado: (2011)

ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study
por: Antlanger, Marlies, et al.
Publicado: (2018)

Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome
por: Goyal, Sagun D., et al.
Publicado: (2015)

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
por: Tomaszewska, Agnieszka, et al.
Publicado: (2021)

Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML
por: Jentzsch, Madlen, et al.
Publicado: (2020)

Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia
por: Abdrabou, Ahmed Kotb, et al.
Publicado: (2021)

Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission
por: Jentzsch, Madlen, et al.
Publicado: (2022)

Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation
por: Fürst, Daniel, et al.
Publicado: (2017)

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
por: Eapen, Mary, et al.
Publicado: (2020)

Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2021)

Recommendations on service delivery to help reduce suffering and anxiety in patients and caregivers post-hematopoietic cell transplantation: a case report
por: Mohammed, Jaleel, et al.
Publicado: (2021)

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
por: Arnold, Staci D., et al.
Publicado: (2017)

Infections in Recipients of Hematopoietic Stem Cell Transplants
por: Young, Jo-Anne H., et al.
Publicado: (2015)

Milestones of Hematopoietic Stem Cell Transplantation – From First Human Studies to Current Developments
por: Juric, Mateja Kralj, et al.
Publicado: (2016)

The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities
por: Hassanein, Mona, et al.
Publicado: (2021)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy
por: Lotz, Laura, et al.
Publicado: (2019)

Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation
por: Coiffard, Benjamin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uskfbr6j520ar2a9lic0b9kcit